Avalon GloboCare Corp.

Avalon GloboCare Corp. is a U.S.-based company with two distinct operating themes: early-stage life sciences commercialization and income-producing real estate. In its recent filings, the company describes research and development work around MIT-linked protein design and CAR-T related intellectual property, alongside commercialization of the KetoAir breathalyzer for ketosis monitoring. It also generates rental revenue from an income-producing property in New Jersey, which provides a separate operating cash flow stream. The business remains development-stage and capital constrained, with management explicitly warning about going concern risk and the need for additional financing.

2

0.11

0.06

— Avalon GloboCare Corp.
%
Consumer health device commercialization40% KetoAir breathalyzer products and related direct-to-consumer commercialization for ketosis monitoring.
Life sciences R&D and IP development20% Patent filings, sponsored research, and co-development work tied to MIT and CAR-T technologies.
Real estate rental income40% Rental revenue from the company's income-producing property in New Jersey.

Avalon GloboCare's commercial customers appear to be consumers and patients interested in ketosis monitoring,...

  • Direct-to-consumer KetoAir buyersprimary

    Individuals purchasing the KetoAir breathalyzer online for ketosis monitoring and personal health tracking.

  • Diabetes and obesity market usersprimary

    Health-conscious consumers and patients targeted because the device is positioned for ketosis-related monitoring in these end markets.

  • Real estate tenantssecondary

    Occupants of the New Jersey property who generate rental revenue for the company.

  • Potential IP partnersemerging

    Biotech or therapeutic partners that could license or collaborate on MIT-linked protein design and CAR-T intellectual property.

The company is headquartered in the United States and maintains cash primarily in U.S...

  • •United States is the main operating base and cash location
  • •New Jersey property generates rental revenue in the U.S.
  • •KetoAir distribution rights cover North America, South America, EU and UK
  • •Small cash balance is held in China, indicating limited foreign exposure
  • •International commercialization is relevant to future growth, not yet scale

Avalon GloboCare's near-term strategy is to commercialize KetoAir while continuing to advance its life sciences...

01
KetoAir commercializationshort-term

The company needs a sellable product with near-term revenue potential to reduce dependence on financing.

02
Advance patent portfoliomedium-term

Protectable IP can create future licensing, partnership, or valuation upside even before product revenue scales.

03
Maintain liquidity through financing and rental incomeshort-term

The company has recurring losses and a going concern warning, so funding continuity is essential.

The most immediate risk is liquidity and going concern pressure, because management states that current cash will not...

critical

Going concern and liquidity shortfall

Management states current cash is insufficient to cover operating expenses for the next twelve months and additional financing is required.

Scope
Company-wide operations and ability to continue as a going concern
Materiality
high
high

Financing and dilution risk

The company expects to raise capital through equity or debt, which may be unavailable or highly dilutive.

Scope
Existing shareholders and future capital structure
Materiality
high
high

Commercialization risk for KetoAir

Sales depend on consumer adoption of a niche ketosis-monitoring device and effective online marketing.

Scope
Product revenue growth
Materiality
high
medium

Early-stage R&D and IP monetization risk

MIT-linked and CAR-T programs are still in development, so patent or partnership value may not materialize.

Scope
Future licensing and valuation upside
Materiality
medium
medium

Interest and derivative volatility

Convertible debt, debt discounts, and derivative liabilities can create large non-operating swings in reported results.

Scope
Net income and EPS
Materiality
medium
Lease accounting for rental income
Revenue timing and rent receivables
Fair value of warrants and embedded conversion features
Non-operating income/expense and balance sheet liabilities
Impairment and useful life estimates
Asset carrying values and future depreciation/amortization
Deferred tax asset valuation allowance
Income tax expense and equity

AIBOTICS, INC.

AIBT · Medicinal Chemicals & Botanical Products

AVALON HOLDINGS CORP

AWX · Refuse Systems

AVALONBAY COMMUNITIES INC

AVB · Real Estate Investment Trusts

Avalo Therapeutics, Inc.

AVTX · Pharmaceutical Preparations

ProtoKinetix, Inc.

PKTX · Pharmaceutical Preparations

EvoAir Holdings Inc.

EVOH · Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip

: 11/08/2026